Rune Labs
Private Company
Total funding raised: $25.6M
Overview
Rune Labs is a private, San Francisco-based digital health company founded in 2018, operating at the intersection of neuroscience, AI, and data analytics. Its core offering is the StrivePD ecosystem, an FDA-cleared platform that uses the Apple Watch to collect Parkinson's symptom data, enabling personalized patient care and providing real-world datasets for clinical research. The company generates revenue by offering its StriveStudy platform and data services to life sciences companies for clinical trials, real-world evidence, and commercial support, while also serving clinicians and patients directly. Rune Labs has established key partnerships with healthcare providers like Kaiser Permanente and biotech firms like BlueRock Therapeutics.
Technology Platform
Cloud-based software and data analytics platform for precision neurology. Integrates multi-modal data from wearables (FDA-cleared Apple Watch integration), patient apps, EMR, and neuromodulation devices. Enables remote patient monitoring, personalized care dashboards for clinicians, and GCP-compliant clinical trial support including digital biomarker development and enriched recruitment.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Rune Labs competes in the digital neurology space with other specialized startups (e.g., Altoida, Koneksa), as well as with the data offerings from large neuromodulation device companies (Medtronic, Boston Scientific). It also faces potential competition from broader digital health platforms and the hardware/OS providers (like Apple) whose devices it relies upon.